Onkure Therapeutics, Inc. · NASDAQ:OKUR
Prosight Management, LP reported a 5.80% stake in Onkure Therapeutics, Inc. (Schedule 13G)
Event Nov 24, 2025 · Filed Nov 28, 2025
Prosight Management, LP reported a 5.80% stake in Onkure Therapeutics, Inc., 745,649 shares, as a passive investor on Nov 24, 2025. Filed Nov 28, 2025 (Schedule 13G).
- Stake
- 5.80%
- Shares
- 745,649
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Prosight Management, LP | 5.80% | 745,649 |
| Prosight Fund, LP | 0.30% | 35,514 |
| Prosight Plus Fund, LP | 1.30% | 163,487 |
| Prosight Partners, LLC | 5.80% | 745,649 |
| W. Lawrence Hawkins | 5.80% | 745,649 |
Source
Related
- Onkure Therapeutics, Inc.
- Prosight Management, LP
- Onkure Therapeutics, Inc. shareholders
- Schedule 13G/A · Prosight Management, LP · Aug 10, 2026
- Schedule 13G · Coastlands Capital LP · Oct 7, 2026
- Form 4 · Saccomano Nicholas A · Sep 23, 2026
- Form 4 · Leverone Jason A. · Sep 23, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Bvf Partners L P · Aug 14, 2026